Cochrane Common Mental Disorders' future

Funding changes

In August 2021, the National Institute for Health Research (NIHR) announced its intention to withdraw the infrastructure funding that it provides to all UK Cochrane Review Groups, including Cochrane Common Mental Disorders. Our funding will cease on 31st March 2023, after which there will be no editorial base to support Cochrane Reviews to publication.

The future of evidence synthesis in Cochrane

In parallel to this, in February 2022, the Cochrane Governing Board approved a new model for producing Cochrane Evidence Syntheses, following an extensive community consultation process. The new model is designed to ensure Cochrane remains viable, sustainable, and focused on the greatest global health and care challenges now and into the future. 

Find out more

What happens next?

As a consequence of these two changes from 2023 our Cochrane review group will no longer exist. However, there will be many new ways for our collaborators and authors to stay connected and part of Cochane's collective culture. 

We are currently in a transition period and many reviews in progress will now be processed through a Central Editorial Service. More information will follow soon.

We are very grateful to all past and current contributors to Cochrane Common Mental Disorders.